Showing results (251-260 of 431) with videos related to
Sort By:
Pageof 44
Cancer|November 25, 2003
Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patientsAmy C Degnim, Kent A Griffith, Michael S Sabel, et al.Nature Nanotechnology|October 1, 2013
Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheetsHyeun Joong Yoon, Tae Hyun Kim, Zhuo Zhang, et al.Molecular Oncology|August 16, 2015
Genotyping concordance in DNA extracted from formalin-fixed paraffin embedded (FFPE) breast tumor and whole blood for pharmacogenetic analysesDaniel L Hertz, Kelley M Kidwell, Jacklyn N Thibert, et al.Breast Cancer Research and Treatment|June 24, 2017
Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patientsDaniel L Hertz, Kelly A Speth, Kelley M Kidwell, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2019
Circulating Tumor Cell Clusters in Patients with Metastatic Breast Cancer: a SWOG S0500 Translational Medicine StudyCostanza Paoletti, Jieling Miao, Emily M Dolce, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancerN Lynn Henry, Faouzi Azzouz, Zereunesay Desta, et al.British Journal of Cancer|January 16, 2020
Tumour-derived extracellular vesicles in blood of metastatic cancer patients associate with overall survivalAfroditi Nanou, M Craig Miller, Leonie L Zeune, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2008
Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapyYan Jin, Daniel F Hayes, Lang Li, et al.Breast Cancer Research and Treatment|August 1, 2016
Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622Anne F Schott, William E Barlow, Catherine H Van Poznak, et al.Breast Cancer Research : BCR|November 30, 2006
Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342Lyndsay N Harris, Gloria Broadwater, Nancy U Lin, et al.Pageof 44